The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Financial Services >> CEO Interviews >> November 4, 2016

Interview with the President and COO: Mack-Cali Realty Corporation (NYSE:CLI)

DeMarco, Michael J.
Michael J. DeMarco serves as President and Chief Operating Officer of the Mack-Cali Realty Corporation. He joined Mack-Cali in 2015 and, along with his partner, Mitchell Rudin, is responsible for the strategic direction of the company. Prior to joining Mack-Cali, Mr. DeMarco was most recently the Chief Investment Officer of CCRE, a nonbank finance company and one of the largest originators of CMBS. He was also an Executive Vice President with Vornado Realty Trust. Prior to that, Mr. DeMarco was a partner at Fortress Investment, overseeing a number of real estate operating companies that Fortress acquired. Additionally, he was a senior managing director with Lehman Brothers in the company’s real estate investment banking unit specializing in mergers and acquisitions, structured finance and initial public offerings. Mr. DeMarco’s current professional affiliations include being on the board of trustees of NAIOP New Jersey and Saint Peter’s Preparatory School, as well as a member of Urban Land Institute and The International Council of Shopping Centers. Mr. DeMarco is a certified public accountant. He received a Bachelor of Business Administration in accounting and a minor in history from Pace University, as well as a Master of Business Administration in finance from the University of Chicago. Profile
TWST: Though Mack-Cali has been around for some time, the company has a relatively new senior management team and new strategy. Would you give us some background on when and why those changes
Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Profitability Strategy Pays Off for Bank IT Company Q2 Holdings
Three Mid-Cap Names Using Their Balance Sheets to Create Value
Look Beyond Traditional Emerging Markets for More Diversification, Less Risk
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy